Comparison of the effect of zingiber and acupressure on nausea and vomiting

Comparison of the effect of zingiber and acupressure on chemotherapy induced nausea and vomiting (CINV) in patients with non-hodgkin's lymphoma

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120109008665N8

Enrollment

Registered

2019-06-04

Start date

2019-06-22

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and Vomiting. Nausea with vomiting, unspecified

Interventions

Intervention 1: Intervention group: All participants in Zingiber intervention group, after assuring the results of the tests, in addition to the routine interventions prescribed by the physician, rece

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Detection of non-Hodgkin's lymphoma by an oncologist and pathologist Age between 18 and 70 years The normal values of hematological and biochemical laboratory values in the Zingiber group Stay at least three courses of chemotherapy The desire to participate in the study

Exclusion criteria

Exclusion criteria: Sensitivity to Zingiber and its consumption over the past week (at first use) The presence of sensitivity and ulcers or any skin problems at the site of use of acupressure wristband Use of blood diluent such as Aspirin, Warfarin, Heparin, Plavix and ... in the Zingiber group. Coagulation disorders (platelets less than 100,000/mm3, etc.) in the Zingiber group Receiving radiotherapy and chemotherapy simultaneously The diseases that lead to nausea and vomiting include liver, kidney, upper gastrointestinal cancer, acute hepatitis B, gastrointestinal obstruction, brain malignancies, high blood pressure, motion sickness, diabetes and electrolyte disorders such as hyponatremia and Hypokalemia Use of alcohol and opium The history of psychiatric problems in patients under treatment with acupressure wristband

Design outcomes

Primary

Measure	Time frame
Severity of nausea and vomiting. Timepoint: Evaluation and measurements will be performed from the first day of chemotherapy up to 5 days after the completion of chemotherapy by the patient. Method of measurement: Morrow Assessment of Nausea and Emesis (MANE).;Frequency of nausea and vomiting. Timepoint: Evaluation and measurements will be performed from the first day of chemotherapy up to 5 days after the completion of chemotherapy by the patient. Method of measurement: Morrow Assessment of Nausea and Emesis (MANE).	—

Measure

Time frame

Severity of nausea and vomiting. Timepoint: Evaluation and measurements will be performed from the first day of chemotherapy up to 5 days after the completion of chemotherapy by the patient. Method of measurement: Morrow Assessment of Nausea and Emesis (MANE).;Frequency of nausea and vomiting. Timepoint: Evaluation and measurements will be performed from the first day of chemotherapy up to 5 days after the completion of chemotherapy by the patient. Method of measurement: Morrow Assessment of Nausea and Emesis (MANE).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Babamohamadi

Semnan University of Medical Sciences

babamohammady2007@gmail.com+98 23 3365 4192

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026